Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates

Frontiers in Endocrinology

Volumn 4, Issue JUN, 2013, Pages

  Fernández Pérez, Leandro ^a   Guerra, Borja ^a   Díaz Chico, Juan C ^a   Flores Morales, A ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Estrogen; Growth hormone; Liver; Metabolism; Sexual dimorphism

Indexed keywords

AMINO ACID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FATTY ACID; GHRELIN; GLUCOSE; GROWTH HORMONE; INSULIN; JANUS KINASE 2; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE Y; SEX HORMONE; STAT3 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; TESTOSTERONE; TRIACYLGLYCEROL;

BODY COMPOSITION; BODY GROWTH; CYP GENE; GENE; GLUCOSE METABOLISM; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LIVER FUNCTION; METABOLISM; NONHUMAN; OBESITY; PLEIOTROPY; PROTEIN PHOSPHORYLATION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84884190294     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00066     Document Type: Review

References (91)

1. Baik, M., Yu, J. H., and Hennighausen, L. (2011). Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Ann. N. Y. Acad. Sci. 1229, 29-37. doi:10.1111/j.1749-6632.2011.06100.x
2. Barclay, J. L., Nelson, C. N., Ishikawa, M., Murray, L. A., Kerr, L. M., McPhee, T. R., et al. (2011). GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology 152, 181-192. doi:10.1210/en.2010-0537
3. Barros, R. P., and Gustafsson, J. A. (2011). Estrogen receptors and the metabolic network. Cell Metab. 14, 289-299. doi:10.1016/j.cmet.2011.08.005
4. Birzniece, V., Meinhardt, U. J., Umpleby, M. A., Handelsman, D. J., and Ho, K. K. (2011). Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver. J. Clin. Endocrinol. Metab. 96, 1060-1067. doi:10.1210/jc.2010-2521
5. Bjornstrom, L., and Sjoberg, M. (2005). Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19, 833-842. doi:10.1210/me.2004-0486
6. Brooks, A. J., Wooh, J. W., Tunny, K. A., and Waters, M. J. (2008). Growth hormone receptor; mechanism of action. Int. J. Biochem. Cell Biol. 40, 1984-1989. doi:10.1016/j.biocel.2007.07.008
7. Brown, R. J., Adams, J. J., Pelekanos, R. A., Wan, Y., McKinstry, W. J., Palethorpe, K., et al. (2005). Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 12, 814-821. doi:10.1038/nsmb977
8. Bryzgalova, G., Lundholm, L., Portwood, N., Gustafsson, J. A., Khan, A., Efendic, S., et al. (2008). Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. Metab. 295, E904-E912. doi:10.1152/ajpendo.90248.2008
9. Burman, P., Johansson, A. G., Siegbahn, A., Vessby, B., and Karlsson, F. A. (1997). Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J. Clin. Endocrinol. Metab. 82, 550-555. doi:10.1210/jc.82.2.550
10. Butler, A. A., and Le Roith, D. (2001). Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu. Rev. Physiol. 63, 141-164. doi:10.1146/annurev.physiol.63.1.141
11. Carro, E., Senaris, R., Considine, R. V., Casanueva, F. F., and Dieguez, C. (1997). Regulation of in vivo growth hormone secretion by leptin. Endocrinology 138, 2203 -2206. doi:10.1210/en.138.5.2203
12. Ceseña, T. I., Cui, T. X., Piwien-Pilipuk, G., Kaplani, J., Calinescu, A. A., Huo, J. S., et al. (2007). Multiple mechanisms of growth hormone-regulated gene transcription. Mol. Genet. Metab. 90, 126-133. doi:10.1016/j.ymgme.2006.10.006
13. Cho, Y., Ariga, M., Uchijima, Y., Kimura, K., Rho, J. Y., Furuhata, Y., et al. (2006). The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats. Endocrinology 147, 5374-5384. doi:10.1210/en.2006-0518
14. Corpas, E., Harman, S. M., and Blackman, M. R. (1993). Human growth hormone and human aging. Endocr. Rev. 14, 20-39. doi:10.1210/edrv-14-1-20
15. Cui, Y., Hosui, A., Sun, R., Shen, K., Gavrilova, O., Chen, W., et al. (2007). Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 46, 504-513. doi:10.1002/hep.21713
16. Dominici, F. P., and Turyn, D. (2002). Growth hormone-induced alterations in the insulin-signaling system. Exp. Biol. Med. (Maywood) 227, 149-157. Eshtiaghi, R., Esteghamati, A., and Nakhjavani, M. (2010). Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 65, 262- 266. doi:10.1016/j.maturitas.2009.11.004
17. Eshtiaghi, R., Esteghamati, A., and Nakhjavani, M. (2010). Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 65, 262- 266. doi:10.1016/j.maturitas.2009.11.004
18. Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T., DiGirolamo, D. J., et al. (2009). Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J. Biol. Chem. 284, 19937-19944. doi:10.1074/jbc.M109.014308
19. Faulds, M. H., Pettersson, K., Gustafsson, J. A., and Haldosen, L. A. (2001). Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms. Mol. Endocrinol. 15, 1929-1940. doi:10.1210/me.15.11.1929
20. Faulds, M. H., Zhao, C., Dahlman-Wright, K., and Gustafsson, J. A. (2012). The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J. Endocrinol. 212, 3-12. doi:10.1530/JOE-11-0044
21. Fernández, L., Flores-Morales, A., Lahuna, O., Sliva, D., Norstedt, G., Haldosén, L. A., et al. (1998). Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology 139, 1815-1824. doi:10.1210/en.139.4.1815
22. Flores-Morales, A., Greenhalgh, C. J., Norstedt, G., and Rico-Bautista, E. (2006). Negative regulation of growth hormone receptor signaling. Mol. Endocrinol. 20, 241-253. doi:10.1210/me.2005-0170
23. Flores-Morales, A., Ståhlberg, N., Tollet-Egnell, P., Lundeberg, J., Malek, R. L., Quackenbush, J., et al. (2001). Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142, 3163-3176. doi:10.1210/en.142.7.3163
24. Foryst-Ludwig, A., and Kintscher, U. (2010). Metabolic impact of estrogen signalling through ERalpha and ERbeta. J. Steroid Biochem. Mol. Biol. 122, 74-81. doi:10.1016/j.jsbmb.2010.06.012
25. Gao, H., Bryzgalova, G., Hedman, E., Khan, A., Efendic, S., Gustafsson, J. A., et al. (2006). Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol. Endocrinol. 20, 1287-1299. doi:10.1210/me.2006-0012
26. Greenhalgh, C. J., Rico-Bautista, E., Lorentzon, M., Thaus, A. L., Morgan, P. O., Willson, T. A., et al. (2005). SOCS2 negatively regulates growth hormone action in vitro and in vivo. J. Clin. Invest. 115, 397-406. doi:10.1172/JCI22710
27. Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., and Cooke, P. S. (2000). Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U.S.A. 97, 12729-12734. doi:10.1073/pnas.97.23.12729
28. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., et al. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931. doi:10.1152/physrev.00026.2006
29. Holst, B., and Schwartz, T. W. (2006). Ghrelin receptor mutations - too little height and too much hunger. J. Clin. Invest. 116, 637-641. doi:10.1172/JCI27999
30. Horvat, S., and Medrano, J. F. (2001). Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics 72, 209-212. doi:10.1006/geno.2000.6441
31. Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., et al. (1996). A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974-977. doi:10.1126/science.273.5277.974
32. Huang, D. S., and O'Sullivan, A. J. (2009). Short-term oral oestrogen therapy dissociates the growth hormone/insulin-like growth factor-I axis without altering energy metabolism in premenopausal women. Growth Horm. IGF Res. 19, 162-167. doi:10.1016/j.ghir.2008.08.009
33. Jones, M. E., Boon, W. C., McInnes, K., Maffei, L., Carani, C., and Simpson, E. R. (2007). Recognizing rare disorders: aromatase deficiency. Nat. Clin. Pract. Endocrinol. Metab. 3, 414-421. doi:10.1038/ncpendmet0477
34. Kaplan, S. A., and Cohen, P. (2007). The somatomedin hypothesis 2007: 50 years later. J. Clin. Endocrinol. Metab. 92, 4529-4535. doi:10.1210/jc.2007-0526
35. Kerrigan, J. R., and Rogol, A. D. (1992). The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr. Rev. 13, 281-298. doi:10.1210/edrv-13-2-281
36. Klover, P., and Hennighausen, L. (2007). Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology 148, 1489-1497. doi:10.1210/en.2006-1431
37. LeRoith, D. (2009). Gender differences in metabolic disorders. Gend. Med. 6(Suppl. 1), 1-3. doi:10.1016/j.genm.2009.02.003
38. LeRoith, D., and Yakar, S. (2007). Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat. Clin. Pract. Endocrinol. Metab. 3, 302-310. doi:10.1038/ncpendmet0427
39. Leung, K. C., Johannsson, G., Leong, G. M., and Ho, K. K. (2004). Estrogen regulation of growth hormone action. Endocr. Rev. 25, 693-721. doi:10.1210/er.2003- 0035
40. Leung, K. C., Waters, M. J., Markus, I., Baumbach, W. R., and Ho, K. K. (1997). Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: a novel mechanism of growth hormone receptor regulation. Proc. Natl. Acad. Sci. U.S.A. 94, 11381-11386. doi:10.1073/pnas.94.21.11381
41. Lewitt, M. S., Denyer, G. S., Cooney, G. J., and Baxter, R. C. (1991). Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 129, 2254-2256. doi:10.1210/endo-129-4-2254
42. Lichanska, A. M., and Waters, M. J. (2008). How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet. 24, 41-47. doi:10.1016/j.tig.2007.10.006
43. List, E. O., Sackmann-Sala, L., Berryman, D. E., Funk, K., Kelder, B., Gosney, E. S., et al. (2011). Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr. Rev. 32, 356-386. doi:10.1210/er.2010-0009
44. Loria, P., Carulli, L., Bertolotti, M., and Lonardo, A. (2009). Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat. Rev. Gastroenterol. Hepatol. 6, 236-247. doi:10.1038/nrgastro.2009.33
45. Lundholm, L., Bryzgalova, G., Gao, H., Portwood, N., Fält, S., Berndt, K. D., et al. (2008). The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J. Endocrinol. 199, 275-286. doi:10.1677/JOE-08-0192
46. Lupu, F., Terwilliger, J. D., Lee, K., Segre, G. V., and Efstratiadis, A. (2001). Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 229, 141-162. doi:10.1006/dbio.2000.9975
47. Mårtensson, U. E., Salehi, S. A., Windahl, S., Gomez, M. F., Swärd, K., Daszkiewicz-Nilsson, J., et al. (2009). Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150, 687-698. doi:10.1210/en.2008-0623
48. Matic, M., Bryzgalova, G., Gao, H., Antonson, P., Humire, P., Omoto, Y., et al. (2013). Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action. PLoS ONE 8, e57458. doi:10.1371/journal.pone.0057458
49. Miller, M. E., Michaylira, C. Z., Simmons, J. G., Ney, D. M., Dahly, E. M., Heath, J. K., et al. (2004). Suppressor of cytokine signaling-2, a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127, 570-581. doi:10.1053/j.gastro.2004.05.016
50. Mode, A., and Gustafsson, J. A. (2006). Sex and the liver - a journey through five decades. Drug Metab. Rev. 38, 197-207. doi:10.1080/03602530600570057
51. Mueller, K. M., Themanns, M., Friedbichler, K., Kornfeld, J. W., Esterbauer, H., Tuckermann, J. P., et al. (2012). Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Mol. Cell. Endocrinol. 361, 1-11. doi:10.1016/j.mce.2012.03.026
52. Munoz, J., Derstine, A., and Gower, B. A. (2002). Fat distribution and insulin sensitivity in postmenopausal women, influence of hormone replacement. Obes. Res. 10, 424-431. doi:10.1038/oby.2002.59
53. Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., et al. (2009). The role of liver-derived insulin-like growth factor-I. Endocr. Rev. 30, 494- 535. doi:10.1210/er.2009-0010
54. Olsson, B., Bohlooly-Y, M., Brusehed, O., Isaksson, O. G., Ahrén, B., Olofsson, S. O., et al. (2003). Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 285, E504-E511.
55. Ono, M., Chia, D. J., Merino-Martinez, R., Flores-Morales, A., Unterman, T. G., and Rotwein, P. (2007). Signal transducer and activator of transcription (Stat) 5bmediated inhibition of insulin-like growth factor binding protein-1 gene transcription, a mechanism for repression of gene expression by growth hormone. Mol. Endocrinol. 21, 1443-1457. doi:10.1210/me.2006-0543
56. Ribas, V., Drew, B. G., Le, J. A., Soleymani, T., Daraei, P., Sitz, D., et al. (2011). Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc. Natl. Acad. Sci. U.S.A. 108, 16457-16462. doi:10.1073/pnas.1104533108
57. Rico-Bautista, E., Flores-Morales, A., and Fernandez-Perez, L. (2006). Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev. 17, 431-439. doi:10.1016/j.cytogfr.2006.09.008
58. Rico-Bautista, E., Negrin-Martinez, C., Novoa-Mogollon, J., Fernandez-Perez, L., and Flores-Morales, A. (2004). Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Exp. Cell Res. 294, 269-280. doi:10.1016/j.yexcr.2003.11.017
59. Riggs, B. L., Khosla, S., and Melton, L. J. III (2002). Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23, 279-302. doi:10.1210/er.23.3.279
60. Rogol, A. D. (2010). Sex steroids, growth hormone, leptin and the pubertal growth spurt. Endocr. Dev. 17, 77-85. doi:10.1159/000262530
61. Rotwein, P. (2012). Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit. Trends Endocrinol. Metab. 23, 186-193. doi:10.1016/j.tem.2012.01.001
62. Rowland, J. E., Lichanska, A. M., Kerr, L. M., White, M., d'Aniello, E. M., Maher, S. L., et al. (2005). In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol. Cell. Biol. 25, 66-77. doi:10.1128/MCB.25.5.2072.2005
63. Sampath, H., and Ntambi, J. M. (2005). Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25, 317-340. doi:10.1146/annurev.nutr.25.051804.101917
64. Santana-Farre, R., Flores-Morales, A., and Fernández-Pérez, L. (2008). "Growth hormone, thyroid hormones and estradiol interplay in vivo to regulate gene expression of suppressors of cytokine signalling (SOCS)," in International Proceedings 13th International Congress of Endocrinology, ed. J. W. A. Godoy-Matos (Rio de Janeiro, Medimond, S.r.l.), 8-12.
65. Simpson, E. R., Misso, M., Hewitt, K. N., Hill, R. A., Boon, W. C., Jones, M. E., et al. (2005). Estrogen - the good, the bad, and the unexpected. Endocr. Rev. 26, 322 -330. doi:10.1210/er.2004-0020
66. Sjoberg, A., Oscarsson, J., Boren, J., Eden, S., and Olofsson, S. O. (1996). Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B-containing lipoproteins in cultured rat hepatocytes. J. Lipid Res. 37, 275-289.
67. Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., et al. (1994). Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331, 1056-1061. doi:10.1056/NEJM199410203311604
68. Sos, B. C., Harris, C., Nordstrom, S. M., Tran, J. L., Balázs, M., Caplazi, P., et al. (2011). Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. J. Clin. Invest. 121, 1412-1423. doi:10.1172/JCI42894
69. Ståhlberg, N., Merino, R., Hernández, L. H., Fernández-Pérez, L., Sandelin, A., Engström, P., et al. (2005). Exploring hepatic hormone actions using a compilation of gene expression profiles. BMC Physiol. 5, 8. doi:10.1186/1472-6793-5-8
70. Stauber, A. J., Brown-Borg, H., Liu, J., Waalkes, M. P., Laughter, A., Staben, R. A., et al. (2005). Constitutive expression of peroxisome proliferator-activated receptor alpha-regulated genes in dwarf mice. Mol. Pharmacol. 67, 681-694. doi:10.1124/mol.104.007278
71. Stofega, M. R., Wang, H., Ullrich, A., and Carter-Su, C. (1998). Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. J. Biol. Chem. 273, 7112-7117. doi:10.1074/jbc.273.12.7112
72. Svensson, J., Lönn, L., Jansson, J. O., Murphy, G., Wyss, D., Krupa, D., et al. (1998). Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab. 83, 362-369. doi:10.1210/jc.83.2.362
73. Tollet-Egnell, P., Flores-Morales, A., Stahlberg, N., Malek, R. L., Lee, N., and Norstedt, G. (2001). Gene expression profile of the aging process in rat liver, normalizing effects of growth hormone replacement. Mol. Endocrinol. 15, 308-318. doi:10.1210/me.15.2.308
74. Tollet-Egnell, P., Parini, P., Ståhlberg, N., Lönnstedt, I., Lee, N. H., Rudling, M., et al. (2004). Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profiles. Physiol. Genomics 16, 261-267.
75. Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S. H., Ram, P. A., et al. (1997). Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 7239-7244. doi:10.1073/pnas.94.14.7239
76. Vesterlund, M., Zadjali, F., Persson, T., Nielsen, M. L., Kessler, B. M., Norstedt, G., et al. (2011). The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS ONE 6, e25358. doi:10.1371/journal.pone.0025358
77. Vidal, O., Lindberg, M. K., Hollberg, K., Baylink, D. J., Andersson, G., Lubahn, D. B., et al. (2000). Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl. Acad. Sci. U.S.A. 97, 5474-5479. doi:10.1073/pnas.97.10.5474
78. Vidal, O. M., Merino, R., Rico-Bautista, E., Fernandez-Perez, L., Chia, D. J., Woelfle, J., et al. (2007). In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol. Endocrinol. 21, 293-311. doi:10.1210/me.2006- 0096
79. Vidarsdottir, S., Walenkamp, M. J., Pereira, A. M., Karperien, M., van Doorn, J., van Duyvenvoorde, H. A., et al. (2006). Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J. Clin. Endocrinol. Metab. 91, 3482-3485. doi:10.1210/jc.2006-0368
80. Vijayakumar, A., Novosyadlyy, R., Wu, Y., Yakar, S., and LeRoith, D. (2010). Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm. IGF Res. 20, 1-7. doi:10.1016/j.ghir.2009.09.002
81. Wang, L., Zhang, X., Farrar, W. L., and Yang, X. (2004). Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. Cell. Mol. Immunol. 1, 416-424.
82. Wang, Z., Masternak, M. M., Al-Regaiey, K. A., and Bartke, A. (2007). Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148, 2845-2853. doi:10.1210/en.2006-1313
83. Waters, M. J., Shang, C. A., Behncken, S. N., Tam, S. P., Li, H., Shen, B., et al. (1999). Growth hormone as a cytokine. Clin. Exp. Pharmacol. Physiol. 26, 760-764. doi:10.1046/j.1440-1681.1999.03129.x
84. Wauthier, V., Sugathan, A., Meyer, R. D., Dombkowski, A. A., and Waxman, D. J. (2010). Intrinsic sex differences in the early growth hormone responsiveness of sex -specific genes in mouse liver. Mol. Endocrinol. 24, 667-678. doi:10.1210/me.2009-0454
85. Waxman, D. J., and Holloway, M. G. (2009). Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 76, 215-228. doi:10.1124/mol.109.056705
86. Waxman, D. J., and O'Connor, C. (2006). Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol. 20, 2613-2629. doi:10.1210/me.2006-0007
87. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M., and Stoffel, M. (2004). Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027-1032. doi:10.1038/nature03047
88. Wolthers, T., Hoffman, D. M., Nugent, A. G., Duncan, M. W., Umpleby, M., and Ho, K. K. (2001). Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab. 281, E1191-E1196.
89. Xu, Y., Nedungadi, T. P., Zhu, L., Sobhani, N., Irani, B. G., Davis, K. E., et al. (2011). Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab. 14, 453-465. doi:10.1016/j.cmet.2011.08.009
90. Yakar, S., Setser, J., Zhao, H., Stannard, B., Haluzik, M., Glatt, V., et al. (2004). Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1- deficient mice. J. Clin. Invest. 113, 96-105. doi:10.1172/JCI200417763
91. Zadjali, F., Santana-Farre, R., Vesterlund, M., Carow, B., Mirecki-Garrido, M., Hernandez-Hernandez, I., et al. (2012). SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J. 26, 3282-3291. doi:10.1096/fj.12-205583